Parabrachial Nucleus (PBn) Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) Signaling in the Amygdala: Implication for the Sensory and Behavioral Effects of Pain
Overview
Pharmacology
Authors
Affiliations
The intricate relationships that associate pain, stress responses and emotional behavior have been well established. Acute stressful situations can decrease nociceptive sensations and conversely, chronic pain can enhance other pain experiences and heighten the emotional and behavioral consequences of stress. Accordingly, chronic pain is comorbid with a number of behavioral disorders including depression, anxiety abnormalities and associated stress-related disorders including post traumatic stress disorder (PTSD). The central nucleus of the amygdala (CeA) represents a convergence of pathways for pain, stress and emotion, and we have identified pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactivity in fiber elements in the lateral capsular division of the CeA (CeLC). The PACAP staining patterns colocalized in part with those for calcitonin gene related peptide (CGRP); anterograde fiber tracing and excitotoxic lesion studies demonstrated that the CeLC PACAP/CGRP immunoreactivities represented sensory fiber projections from the lateral parabrachial nucleus (LPBn) along the spino-parabrachioamygdaloid tract. The same PBn PACAP/CGRP fiber system also projected to the BNST. As in the BNST, CeA PACAP signaling increased anxiety-like behaviors accompanied by weight loss and decreased feeding. But in addition to heightened anxiety-like responses, CeA PACAP signaling also altered nociception as reflected by decreased latency and threshold responses in thermal and mechanical sensitivity tests, respectively. From PACAP expression in major pain pathways, the current observations are novel and suggest that CeA PACAP nociceptive signaling and resulting neuroplasticity via the spino-parabrachioamygdaloid tract may represent mechanisms that associate chronic pain with sensory hypersensitivity, fear memory consolidation and severe behavioral disorders.
Singh A, Shim P, Naeem S, Rahman S, Lutfy K Front Psychiatry. 2025; 15:1495598.
PMID: 39931196 PMC: 11807976. DOI: 10.3389/fpsyt.2024.1495598.
Ebner K, Fontebasso V, Ferro F, Singewald N, Hannibal J Neuropsychopharmacology. 2024; 50(3):519-530.
PMID: 39472527 PMC: 11735793. DOI: 10.1038/s41386-024-02016-9.
Meloni E, Carlezon Jr W, Bolshakov V Sci Rep. 2024; 14(1):8919.
PMID: 38637645 PMC: 11026503. DOI: 10.1038/s41598-024-59459-9.
Granger S, May V, Hammack S, Akman E, Jobson S, Olson E Eur J Psychotraumatol. 2024; 15(1):2335793.
PMID: 38590134 PMC: 11005872. DOI: 10.1080/20008066.2024.2335793.
Evidence for chronic headaches induced by pathological changes of myodural bridge complex.
Song X, Yu S, Yuan X, Alam Shah M, Li C, Chi Y Sci Rep. 2024; 14(1):5285.
PMID: 38438423 PMC: 10912660. DOI: 10.1038/s41598-024-55069-7.